Listed

Precigen, Inc.

PGENNasdaqCIK 1356090HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$55.0m, Q2 FY2026
Operating income$22.6m, Q2 FY2026
Net income$20.1m, Q2 FY2026
Precigen, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$mnot reportednot reportednot reportednot reportednot reportednot reported1.3Revenue, Q1 FY2025, three months to 2025-03-31$1.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure0.9Revenue, Q2 FY2025, three months to 2025-06-30$856.0k. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figurenot reportednot reported23.3Revenue, Q1 FY2026, three months to 2026-03-31$23.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure55.0Revenue, Q2 FY2026, three months to 2026-06-30$55.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Cost of revenue$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Research and development$mnot reportednot reportednot reportednot reportednot reportednot reported10.5Research and development, Q1 FY2025, three months to 2025-03-31$10.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure11.5Research and development, Q2 FY2025, three months to 2025-06-30$11.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figurenot reportednot reported5.6Research and development, Q1 FY2026, three months to 2026-03-31$5.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure7.3Research and development, Q2 FY2026, three months to 2026-06-30$7.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reported12.4Selling, general and administrative, Q1 FY2025, three months to 2025-03-31$12.4m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure16.1Selling, general and administrative, Q2 FY2025, three months to 2025-06-30$16.1m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figurenot reportednot reported21.0Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$21.0m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure22.2Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$22.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Operating income$mnot reportednot reportednot reportednot reportednot reportednot reported(22.6)Operating income, Q1 FY2025, three months to 2025-03-31−$22.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure(31.8)Operating income, Q2 FY2025, three months to 2025-06-30−$31.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figurenot reportednot reported(6.0)Operating income, Q1 FY2026, three months to 2026-03-31−$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure22.6Operating income, Q2 FY2026, three months to 2026-06-30$22.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Interest expense$mnot reportednot reportednot reportednot reportednot reportednot reported0.0Interest expense, Q1 FY2025, three months to 2025-03-31$1.0k. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figurenot reportednot reported2.9Interest expense, Q1 FY2026, three months to 2026-03-31$2.9m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure3.0Interest expense, Q2 FY2026, three months to 2026-06-30$3.0m. XBRL concept us-gaap:InterestExpenseNonoperating. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Income tax$m(0.0)Income tax, Q3 FY2023, three months to 2023-09-30−$6.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-14, accession 0001356090-24-000026.Report this figure(0.3)Income tax, Q4 FY2023, three months to 2023-12-31−$332.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-25, accession 0001356090-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(0.0)Income tax, Q1 FY2024, three months to 2024-03-31−$29.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-14, accession 0001356090-25-000019.Report this figure(1.7)Income tax, Q2 FY2024, three months to 2024-06-30−$1.7m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-12, accession 0001356090-25-000024.Report this figure0.0Income tax, Q3 FY2024, three months to 2024-09-30$12.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure(0.1)Income tax, Q4 FY2024, three months to 2024-12-31−$87.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-25, accession 0001356090-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$3.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure0.0Income tax, Q3 FY2025, three months to 2025-09-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figurenot reported0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Net income$m(19.8)Net income, Q3 FY2023, three months to 2023-09-30−$19.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-14, accession 0001356090-24-000026.Report this figure(33.1)Net income, Q4 FY2023, three months to 2023-12-31−$33.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001356090-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(23.7)Net income, Q1 FY2024, three months to 2024-03-31−$23.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-14, accession 0001356090-25-000019.Report this figure(58.8)Net income, Q2 FY2024, three months to 2024-06-30−$58.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-12, accession 0001356090-25-000024.Report this figure(24.0)Net income, Q3 FY2024, three months to 2024-09-30−$24.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure(19.7)Net income, Q4 FY2024, three months to 2024-12-31−$19.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001356090-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(54.2)Net income, Q1 FY2025, three months to 2025-03-31−$54.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure(26.6)Net income, Q2 FY2025, three months to 2025-06-30−$26.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure(146)Net income, Q3 FY2025, three months to 2025-09-30−$146.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure(23.5)Net income, Q4 FY2025, three months to 2025-12-31−$23.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001356090-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(7.9)Net income, Q1 FY2026, three months to 2026-03-31−$7.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure20.1Net income, Q2 FY2026, three months to 2026-06-30$20.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Diluted EPS$ per share(0.08)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-14, accession 0001356090-24-000026.Report this figurenot reported(0.10)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-14, accession 0001356090-25-000019.Report this figure(0.23)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-12, accession 0001356090-25-000024.Report this figure(0.09)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figurenot reported(0.18)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure(0.09)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure(1.06)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.06 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figurenot reported(0.02)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure0.05Diluted EPS, Q2 FY2026, three months to 2026-06-30$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Basic EPS$ per share(0.08)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-14, accession 0001356090-24-000026.Report this figurenot reported(0.10)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.10 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-14, accession 0001356090-25-000019.Report this figure(0.23)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.23 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-12, accession 0001356090-25-000024.Report this figure(0.09)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figurenot reported(0.18)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure(0.09)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.09 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure(1.06)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figurenot reported(0.02)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure0.06Basic EPS, Q2 FY2026, three months to 2026-06-30$0.06 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure

Balance sheet

Cash and equivalents$16.3m, Q2 FY2026
Long-term debt$93.9m, Q2 FY2026
Shareholders' equity$43.6m, Q2 FY2026
Precigen, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m10.1Cash and equivalents, Q3 FY2023, at 2023-09-30$10.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-09, accession 0001356090-23-000017.Report this figure7.6Cash and equivalents, FY2023, at 2023-12-31$7.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-19, accession 0001356090-25-000007.Report this figure17.5Cash and equivalents, Q1 FY2024, at 2024-03-31$17.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-14, accession 0001356090-24-000010.Report this figure9.3Cash and equivalents, Q2 FY2024, at 2024-06-30$9.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001356090-24-000017.Report this figure24.7Cash and equivalents, Q3 FY2024, at 2024-09-30$24.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-14, accession 0001356090-24-000026.Report this figure29.5Cash and equivalents, FY2024, at 2024-12-31$29.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-25, accession 0001356090-26-000009.Report this figure6.1Cash and equivalents, Q1 FY2025, at 2025-03-31$6.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-14, accession 0001356090-25-000019.Report this figure13.8Cash and equivalents, Q2 FY2025, at 2025-06-30$13.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-12, accession 0001356090-25-000024.Report this figure14.3Cash and equivalents, Q3 FY2025, at 2025-09-30$14.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure30.2Cash and equivalents, FY2025, at 2025-12-31$30.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure7.5Cash and equivalents, Q1 FY2026, at 2026-03-31$7.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure16.3Cash and equivalents, Q2 FY2026, at 2026-06-30$16.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Current assets$m93.0Current assets, Q3 FY2023, at 2023-09-30$93.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-09, accession 0001356090-23-000017.Report this figure68.8Current assets, FY2023, at 2023-12-31$68.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-19, accession 0001356090-25-000007.Report this figure49.5Current assets, Q1 FY2024, at 2024-03-31$49.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-14, accession 0001356090-24-000010.Report this figure23.7Current assets, Q2 FY2024, at 2024-06-30$23.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001356090-24-000017.Report this figure34.5Current assets, Q3 FY2024, at 2024-09-30$34.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-14, accession 0001356090-24-000026.Report this figure102Current assets, FY2024, at 2024-12-31$102.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-25, accession 0001356090-26-000009.Report this figure84.6Current assets, Q1 FY2025, at 2025-03-31$84.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-14, accession 0001356090-25-000019.Report this figure62.8Current assets, Q2 FY2025, at 2025-06-30$62.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-12, accession 0001356090-25-000024.Report this figure130Current assets, Q3 FY2025, at 2025-09-30$129.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure115Current assets, FY2025, at 2025-12-31$115.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure102Current assets, Q1 FY2026, at 2026-03-31$101.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure134Current assets, Q2 FY2026, at 2026-06-30$134.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Total assets$m191Total assets, Q3 FY2023, at 2023-09-30$190.7m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-09, accession 0001356090-23-000017.Report this figure151Total assets, FY2023, at 2023-12-31$151.0m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-19, accession 0001356090-25-000007.Report this figure135Total assets, Q1 FY2024, at 2024-03-31$134.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-14, accession 0001356090-24-000010.Report this figure73.2Total assets, Q2 FY2024, at 2024-06-30$73.2m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001356090-24-000017.Report this figure83.5Total assets, Q3 FY2024, at 2024-09-30$83.5m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-14, accession 0001356090-24-000026.Report this figure145Total assets, FY2024, at 2024-12-31$145.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-25, accession 0001356090-26-000009.Report this figure129Total assets, Q1 FY2025, at 2025-03-31$128.8m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-14, accession 0001356090-25-000019.Report this figure102Total assets, Q2 FY2025, at 2025-06-30$101.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-12, accession 0001356090-25-000024.Report this figure171Total assets, Q3 FY2025, at 2025-09-30$171.3m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure156Total assets, FY2025, at 2025-12-31$155.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure139Total assets, Q1 FY2026, at 2026-03-31$138.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure170Total assets, Q2 FY2026, at 2026-06-30$170.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Current liabilities$m32.9Current liabilities, Q3 FY2023, at 2023-09-30$32.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-09, accession 0001356090-23-000017.Report this figure23.0Current liabilities, FY2023, at 2023-12-31$23.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-19, accession 0001356090-25-000007.Report this figure28.8Current liabilities, Q1 FY2024, at 2024-03-31$28.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-14, accession 0001356090-24-000010.Report this figure23.0Current liabilities, Q2 FY2024, at 2024-06-30$23.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001356090-24-000017.Report this figure21.2Current liabilities, Q3 FY2024, at 2024-09-30$21.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-14, accession 0001356090-24-000026.Report this figure21.5Current liabilities, FY2024, at 2024-12-31$21.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-25, accession 0001356090-26-000009.Report this figure24.0Current liabilities, Q1 FY2025, at 2025-03-31$24.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-14, accession 0001356090-25-000019.Report this figure23.2Current liabilities, Q2 FY2025, at 2025-06-30$23.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-12, accession 0001356090-25-000024.Report this figure32.1Current liabilities, Q3 FY2025, at 2025-09-30$32.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure37.3Current liabilities, FY2025, at 2025-12-31$37.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure21.1Current liabilities, Q1 FY2026, at 2026-03-31$21.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure29.4Current liabilities, Q2 FY2026, at 2026-06-30$29.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Total liabilities$m43.0Total liabilities, Q3 FY2023, at 2023-09-30$43.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-09, accession 0001356090-23-000017.Report this figure32.5Total liabilities, FY2023, at 2023-12-31$32.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-19, accession 0001356090-25-000007.Report this figure37.8Total liabilities, Q1 FY2024, at 2024-03-31$37.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-14, accession 0001356090-24-000010.Report this figure30.0Total liabilities, Q2 FY2024, at 2024-06-30$30.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001356090-24-000017.Report this figure28.1Total liabilities, Q3 FY2024, at 2024-09-30$28.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-14, accession 0001356090-24-000026.Report this figure78.5Total liabilities, FY2024, at 2024-12-31$78.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-25, accession 0001356090-26-000009.Report this figure113Total liabilities, Q1 FY2025, at 2025-03-31$113.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-14, accession 0001356090-25-000019.Report this figure108Total liabilities, Q2 FY2025, at 2025-06-30$107.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-12, accession 0001356090-25-000024.Report this figure129Total liabilities, Q3 FY2025, at 2025-09-30$129.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure135Total liabilities, FY2025, at 2025-12-31$134.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure118Total liabilities, Q1 FY2026, at 2026-03-31$118.4m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure127Total liabilities, Q2 FY2026, at 2026-06-30$126.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reported0.0Long-term debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-K filed 2026-03-25, accession 0001356090-26-000009.Report this figurenot reportednot reported92.9Long-term debt, Q3 FY2025, at 2025-09-30$92.9m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure93.2Long-term debt, FY2025, at 2025-12-31$93.2m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure93.5Long-term debt, Q1 FY2026, at 2026-03-31$93.5m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure93.9Long-term debt, Q2 FY2026, at 2026-06-30$93.9m. XBRL concept us-gaap:LongTermDebtNoncurrent. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Short-term borrowings$m0.0Short-term borrowings, Q3 FY2023, at 2023-09-30$0. XBRL concept us-gaap:ShortTermBorrowings. 10-Q filed 2023-11-09, accession 0001356090-23-000017.Report this figure0.0Short-term borrowings, FY2023, at 2023-12-31$0. XBRL concept us-gaap:ShortTermBorrowings. 10-K filed 2024-03-19, accession 0001356090-24-000007.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m148Shareholders' equity, Q3 FY2023, at 2023-09-30$147.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-14, accession 0001356090-24-000026.Report this figure118Shareholders' equity, FY2023, at 2023-12-31$118.5m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-25, accession 0001356090-26-000009.Report this figure97.0Shareholders' equity, Q1 FY2024, at 2024-03-31$97.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-12, accession 0001356090-25-000024.Report this figure43.2Shareholders' equity, Q2 FY2024, at 2024-06-30$43.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure55.4Shareholders' equity, Q3 FY2024, at 2024-09-30$55.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure38.5Shareholders' equity, FY2024, at 2024-12-31$38.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure(14.1)Shareholders' equity, Q1 FY2025, at 2025-03-31−$14.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure(36.8)Shareholders' equity, Q2 FY2025, at 2025-06-30−$36.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure41.9Shareholders' equity, Q3 FY2025, at 2025-09-30$41.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure20.9Shareholders' equity, FY2025, at 2025-12-31$20.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure20.2Shareholders' equity, Q1 FY2026, at 2026-03-31$20.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure43.6Shareholders' equity, Q2 FY2026, at 2026-06-30$43.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure

Cash flow

Operating cash flow−$17.8m, Q2 FY2026
Capital expenditure$392.0k, Q2 FY2026
Precigen, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(17.0)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$17.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-14, accession 0001356090-24-000026. Derived: 9-month figure less the 6-month figure.Report this figure(15.8)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$15.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001356090-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(14.1)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$14.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-14, accession 0001356090-25-000019.Report this figure(23.1)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$23.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-12, accession 0001356090-25-000024. Derived: 6-month figure less the 3-month figure.Report this figure(22.7)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$22.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001356090-25-000034. Derived: 9-month figure less the 6-month figure.Report this figure(8.2)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001356090-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(16.3)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$16.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure(19.0)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$19.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001356090-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure(29.1)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$29.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-13, accession 0001356090-25-000034. Derived: 9-month figure less the 6-month figure.Report this figure(23.5)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$23.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001356090-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure(43.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$43.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure(17.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$17.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-04, accession 0001356090-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$236.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-14, accession 0001356090-24-000026. Derived: 9-month figure less the 6-month figure.Report this figure1.0Capital expenditure, Q4 FY2023, three months to 2023-12-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001356090-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure4.4Capital expenditure, Q1 FY2024, three months to 2024-03-31$4.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-14, accession 0001356090-25-000019.Report this figure2.3Capital expenditure, Q2 FY2024, three months to 2024-06-30$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-12, accession 0001356090-25-000024. Derived: 6-month figure less the 3-month figure.Report this figure0.9Capital expenditure, Q3 FY2024, three months to 2024-09-30$882.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001356090-25-000034. Derived: 9-month figure less the 6-month figure.Report this figure1.0Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001356090-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure0.6Capital expenditure, Q1 FY2025, three months to 2025-03-31$622.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure1.0Capital expenditure, Q2 FY2025, three months to 2025-06-30$966.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001356090-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$389.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-13, accession 0001356090-25-000034. Derived: 9-month figure less the 6-month figure.Report this figure0.0Capital expenditure, Q4 FY2025, three months to 2025-12-31$18.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-25, accession 0001356090-26-000009. Derived: 12-month figure less the 9-month figure.Report this figure0.3Capital expenditure, Q1 FY2026, three months to 2026-03-31$258.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure0.4Capital expenditure, Q2 FY2026, three months to 2026-06-30$392.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-04, accession 0001356090-26-000030. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)413.69m, Q2 FY2026
Precigen, Inc., shares, quarterly
Line itemUnitQ3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares201Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30200,670,590 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-09, accession 0001356090-23-000017.Report this figure230Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31229,770,381 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-14, accession 0001356090-24-000010.Report this figure248Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30248,003,322 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001356090-24-000017.Report this figure249Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30248,520,724 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-14, accession 0001356090-24-000026.Report this figure249Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31249,220,335 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-14, accession 0001356090-25-000019.Report this figure252Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30252,366,533 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-12, accession 0001356090-25-000024.Report this figure276Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30275,881,170 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure294Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31293,879,653 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure296Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30296,434,726 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure307Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30307,170,490 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-13, accession 0001356090-25-000034.Report this figure354Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31354,291,007 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-13, accession 0001356090-26-000017.Report this figure414Diluted shares (weighted), Q2 FY2026, three months to 2026-06-30413,686,865 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure

Shares outstanding: 358.04mShares outstanding, period not labelled, at 2026-07-31358,035,247 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-04, accession 0001356090-26-000030.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 4, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:37 ET. Listed shows no prices and gives no investment advice.